PRP (platelet-rich plasma) and exosome therapy are increasingly marketed together as "regenerative" hair loss treatments. But they occupy completely different positions on the evidence spectrum — and lumping them together does a disservice to patients trying to make informed decisions.
PRP has a growing body of clinical evidence, including multiple randomized controlled trials and meta-analyses. Exosomes have zero FDA-approved products, active enforcement actions against companies selling them, and a track record of serious adverse events.
This guide gives you the data on both so you can distinguish legitimate treatment from marketing hype.
PRP for Hair Loss: What the Evidence Shows
How PRP Works
PRP therapy involves drawing your blood, spinning it in a centrifuge to concentrate the platelets (which contain growth factors), and injecting the concentrated plasma directly into thinning areas of the scalp. The growth factors — including PDGF, VEGF, and TGF-β — theoretically stimulate dormant follicles, promote angiogenesis (new blood vessel formation), and extend the anagen (growth) phase of the hair cycle.
The Clinical Evidence
A 2025 systematic review and meta-analysis published in Dermatology and Therapy — the largest to date — analyzed 43 randomized controlled trials involving 1,877 participants. The findings: activated PRP significantly increased hair density and reduced recurrence compared to placebo. Patient satisfaction was generally favorable, and clinical improvement was often comparable or superior to conventional treatments.
Separately, a 2025 systematic review in Skin Health and Disease comparing PRP to topical minoxidil across six clinical trials found that PRP's efficacy was roughly comparable to topical minoxidil — with PRP showing more improvement in hair density and minoxidil showing more improvement in terminal hair count.
PRP Evidence Summary
What works: Moderate evidence supports PRP for increasing hair density, with 70–80% of early-to-moderate AGA patients seeing benefit in clinical studies. Best results in Norwood I–III (early-stage loss).
What doesn't: Limited evidence for hair thickness improvement. Results require maintenance sessions. High variability between clinics due to non-standardized preparation protocols.
PRP Costs and Protocol
| Factor | Typical Range |
|---|---|
| Cost per session | $400–$1,500 |
| Initial protocol | 3–4 sessions, spaced 4–6 weeks apart |
| Maintenance | Every 6–12 months |
| Results timeline | 3–6 months for visible improvement |
| Results duration | 12–18 months before fading without maintenance |
| Insurance coverage | Almost never covered (considered cosmetic) |
The biggest practical challenge with PRP: there's no standardized preparation protocol. Different clinics use different centrifuge systems, platelet concentrations, activation methods, and injection techniques. This variability means results can differ significantly from one provider to another.
Who Should Consider PRP
PRP makes the most sense as a complement to — not a replacement for — finasteride and minoxidil. If you're already on a solid medication regimen and want to maximize results, PRP may provide additional benefit. It's also an option for people who can't tolerate medications or want a non-pharmaceutical adjunct.
PRP is not a standalone solution for progressive androgenetic alopecia. Without addressing the underlying DHT-driven miniaturization via medication, PRP's benefits will be overwhelmed by ongoing hair loss.
Start With the Proven Foundation First
Medication is the first line of defense. Get a clinical evaluation to build the right treatment plan — PRP can be added later.
Get Evaluated → Sesame CareExosome Therapy for Hair Loss: The FDA Warning
Critical Warning
There are zero FDA-approved exosome products for any medical use — including hair loss. The FDA has issued a public safety notification, warning letters to manufacturers, and continues active enforcement in 2025–2026. Any clinic offering exosome "treatment" for hair loss is operating outside FDA approval.
What Exosomes Are
Exosomes are tiny membrane-bound vesicles (30–150 nanometers) that cells release as communication vehicles. They carry proteins, lipids, and RNA that can influence surrounding cells. In laboratory settings, exosomes derived from stem cells have shown potential to stimulate tissue repair and regeneration.
The research is genuinely interesting from a scientific perspective. But research interest and clinical readiness are separated by years of clinical trials, safety validation, and regulatory approval — none of which has occurred for any exosome product.
The FDA Enforcement Record
The FDA's position is unambiguous: exosomes used to treat diseases and conditions in humans are regulated as drugs and biological products, requiring premarket review and approval. Key enforcement actions include:
- 2023: Warning letter to Kimera Labs (Florida) for distributing XoGlo, XoGlo Pro, and Amnio2X exosome products without an approved BLA/IND. The letter documented distribution of unapproved drug products and cGMP violations.
- Early 2025: Warning to Chara Biologics (California) that its "CharaExo" amniotic fluid-derived exosome therapy was an unapproved new drug and unlicensed biological product.
- Late 2024: Warning to Evolutionary Biologics about its "EXO RNA" product, confirming it meets the definition of a drug and biological product requiring premarket review.
- Ongoing: FDA public safety notification citing serious adverse events in patients treated with unapproved exosome products, including hospitalizations.
What This Means for Patients
If a clinic is offering you exosome therapy for hair loss in 2026, they are selling you an unproven, unapproved product. The claims they make about effectiveness are unsubstantiated. The safety profile is uncharacterized. And the FDA considers their operation non-compliant.
This doesn't mean exosomes will never have a role in hair treatment — the science is early but interesting. It means today, in 2026, there is no legitimate exosome treatment available for hair loss. If exosome research validates the approach, it will go through clinical trials and regulatory approval like any other treatment.
PRP vs. Exosomes: The Comparison
| Criteria | PRP | Exosomes |
|---|---|---|
| FDA status | Legal — uses your own blood (autologous) | Zero FDA-approved products |
| Clinical evidence | 43+ RCTs, multiple meta-analyses | Lab/preclinical only |
| Safety record | Excellent — minimal adverse events (autologous) | FDA reports serious adverse events |
| Standardization | Low — protocols vary by provider | None — products uncharacterized |
| Cost per session | $400–$1,500 | $500–$5,000+ |
| Recommendation | Reasonable adjunct to medication | Avoid until FDA-approved products exist |
Proven Alternatives Are Available Now
Custom-compounded topical treatments with multiple active ingredients — clinically guided, no injection needed.
See Custom Plans → Happy HeadThe Bottom Line
PRP is a legitimate treatment with moderate evidence and an excellent safety profile. It's not a miracle cure, it's expensive, and it works best as a complement to proven medications rather than a standalone solution. But the science behind it is real and growing.
Exosome therapy, as currently marketed, is an unproven product that exists outside FDA approval. No matter how compelling the marketing, no matter how scientific the clinic's website looks, there are zero approved exosome products for hair loss. If a clinic tries to sell you exosome therapy, consider it a red flag about that clinic's commitment to evidence-based practice.
For the vast majority of people with hair loss, the best approach remains what it's been for years: finasteride, minoxidil, and combination therapy. PRP can supplement that foundation. Exosomes cannot — at least not yet.